코오롱티슈진

950160KOSDAQView the 제약 sectorTheme Bio & healthcare

14,760KRWMarket close of 10/27 (Tue)

Up +0.27%+40KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)14,600KRWDown -1.08%

Preliminary · replaced once official KRX data for the same date is published

Open
14,870
High
15,230
Low
14,210
Day range
Day range low 14,210 high 15,230, open 14,870, close 14,760, previous close 14,720
Volume
21×10K shares
3.2B KRW 0.40× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 11,670 to 138,800 won, 2% up from the low

2% of the way up from the lowest close in 1 year (252 sessions) · -89.4% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedCould not read filing data, so not verified
  • Daily moveusual range+0.27%+0.27%, 0.1× the usual (20-session average ±3.91%)
    That day +0.27% · usual ±3.91% · large-move threshold ±7.8%

The other 2 are within the usual range

  • Trading value0.4×usual range
  • Foreign & institutional+500.00 million KRWusual range
See the full check report

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Schedule

  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.